Clinical Study of Shatyadi Churna And Vasadi Kashaya With And Without Nitya Virechana In The Management Of Tamak Shwasa W.S.R. COPD

"Randomized Comparative Clinical Evaluation Of Shatyadi Churna and Vasadi Kashaya with and without Nitya Virechana in the management of Tamaka Shwasa w.s.r to Chronic Obstructive Pulmonary Disease"

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027722

Enrollment

Registered

2020-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Shatyadi churna , Vashadi kashaya and Shodhana Ghrita: Group A :In the trial group A, 20 patients of Tamaka Shwasa roga i.e. COPD will be administered Shatyadi churna (dose 5gm) and Vas

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects willing to participate in this clinical trial. 2. Patients in the age group of 30 to 70 years of either sex. 3. Patients who have FEV1/FVC <0.7 on post bronchodilator spirometry.

Exclusion criteria

Exclusion criteria: 1. Age below 30 and above 70years of age. 2. Patients suffering from Pulmonary Tuberculosis, Pleural effusion. 3. Patients suffering from Bronchiectasis. 4. Patient suffering from Bronchial Asthma. 5. Patients suffering from congestive heart failure. 6. Patients suffering from Bronchogenic carcinoma or other form of malignancies. 7. Status asthmaticus. 8. Patients with Haemoglobin less than 9 mg/dl. 9. Pregnant and lactating women. 10. Patients suffering from serious systemic disorders like Renal diseases, Ischemic heart Disease, Malignant Hypertension, uncontrolled Diabetes Mellitus.

Design outcomes

Primary

Measure	Time frame
Changes in the sign & symptoms of Tamak Shwasa w.s.r. to COPDTimepoint: 30 days	—

Secondary

Measure	Time frame
Changes in the pulmonary function test i.e. improvement in the PFT parametersTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Vikash Kumar Vikrant

National Institute of Ayurveda

dr.abhishek82@gmail.com9915613039

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026